Thrombosis in otherwise well children with the factor V Leiden mutation

Journal of Pediatrics

Volumn 128, Issue 3, 1996, Pages 324-328

  Sifontes, M T ^a   Nuss, R ^a   Jacobson, L J ^a   Griffin, J H ^a   Manco Johnson, M J ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5; PROTEIN C;

ADOLESCENT; ADULT; ARTICLE; BLOOD CLOTTING FACTOR 5 DEFICIENCY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERLIPIDEMIA; MALE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN S DEFICIENCY; RISK FACTOR; THROMBOSIS;

EID: 0030009287     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(96)70275-5     Document Type: Article

References (28)

1. T Koster FR Rosendaal H De Ronde E Briet JP Vandenbroucke RM Bertina Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilia study Lancet 342 1993 1503 1506
2. PJ Svenson B Dahlback Resistance to activated protein C as a basis for venous thrombosis N Engl J Med 330 1994 517 522
3. B Dahlback Inherited thrombophilia: resistance to activated protein C as a pathogenic factor of venous thromboembolism Blood 85 1995 607 614
4. FR Rosendaal T Koster JP Vandenbroucke PH Reitsma High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance) Blood 85 1995 1504 1508
5. JH Griffin B Evatt C Wideman JA Fernandez Anticoagulant protein C pathway defective in the majority of thrombophilic patients Blood 82 1993 1989 1993
6. R Nuss T Hays M Manco-Johnson Childhood thrombosis Pediatrics 96 1995 291 294
7. B Dahlback M Carlson P Svenson Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C Proc Natl Acad Sci USA 90 1993 1004 1008
8. H De Ronde RM Bertina Laboratory diagnosis of APC-resistance: a critical evaluation of the test and the development of diagnostic criteria Thromb Haemost 72 1994 880 886
9. JS Greengard S Eichenger JS Griffin KS Bauer Brief report: variability of thrombosis among homozygous siblings with resistance to activated protein C due to an Arg-Gln mutation in the gene for factor V N Engl J Med 331 1994 1559 1562
10. GRV Hughes EN Harris AE Gharavi The anticardiolipin syndrome J Rheumatol 133 1986 486 489
11. J Sambrano LJ Jacobson E Reeve W Hathaway Abnormal antithrombin III with defective serine protease binding (antithrombin III “Denver”) J Clin Invest 77 1986 887 893
12. MJ Manco-Johnson TC Abshire LJ Jacobson RA Marlar Severe neonatal protein C deficiency: prevalence and thrombotic risk J PEDIATR 119 1991 793 798
13. HC Urschel MA Razzuk Improved management of the Paget-Schroetter syndrome secondary to thoracic outlet compression Ann Thorac Surg 52 1991 1217 1221
14. J Kunkel HI Machleder Treatment of Paget-Schroetter syndrome Arch Surg 124 1989 1153 1157
15. AF AbuRahma D Sadler P Stuart MZ Zhan JP Boland Conventional versus thrombolytic therapy in spontaneous (effort) axillary-subclavian vein thrombosis Am J Surg 161 1991 459 465
16. WE Hathaway SH Goodnight Jr Disorders of hemostasis and thrombosis 1993 McGraw-Hill New York
17. R Bertina BPC Koeleman T Koster Mutation in blood coagulation factor V associated with resistance to activated protein C Nature 369 1994 64 67
18. 506-Gln mutation in factor Va Lancet 343 1994 1361 1362
19. 506 of factor V Lancet 343 1994 1535 1536
20. X Sun B Evatt JH Griffin Blood coagulation factor Va abnormality associated with resistance to activated protein C in venous thrombophilia Blood 83 1994 3120 3125
21. B Zoller H Xuhua B Dahlback Homozygous APC-resistance combined with inherited type I protein S deficiency in a young boy with severe thrombotic disease Thromb Haemost 73 1995 743 745
22. B Zoller A Bernstoddler T Garcia de Frutos B Dahlback Resistance to activated protein C as an additional risk factor in hereditary genetic deficiency of protein S Blood 85 1995 3518 3524
23. BPC Koeleman PH Reitsma CF Allart RM Bertina Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families Blood 84 1994 1031 1035
24. S Gandrille JS Greengard M Alhenc-Gelas Incidence of activated protein C resistance caused by the ARG 506 GLN mutation in factor V in 113 unrelated symptomatic protein C-deficient patients Blood 86 1995 219 224
25. J Petäjä H Jalanko C Holmberg S Kinnunen M Syrjälä Resistance to activated protein C as an underlying cause of recurrent venous thrombosis during relapsing nephrotic syndrome J PEDIATR 127 1995 103 105
26. 4053
27. 506-factor V Blood 85 1995 3405 3411
28. 506 to Gln mutation in the factor V gene and venous thrombosis Thromb Haemost 73 1995 739 742